SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6TM'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N6C_A_SAMA402_0 (SETDOMAIN-CONTAININGPROTEIN 7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.40A | 1n6cA-5kjmA:6.7 | 1n6cA-5kjmA:21.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_A_SAMA801_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 10 | GLY A 18ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.63A | 2h21A-5kjmA:10.5 | 2h21A-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_A_SAMA801_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 10 | GLY A 20HIS A 207TYR A 240TYR A 258PHE A 260 | NoneNone6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 1.17A | 2h21A-5kjmA:10.5 | 2h21A-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_A_SAMA801_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 10 | GLY A 20LEU A 21TYR A 240TYR A 258PHE A 260 | NoneNone6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 1.46A | 2h21A-5kjmA:10.5 | 2h21A-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_B_SAMB802_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.55A | 2h21B-5kjmA:12.7 | 2h21B-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_B_SAMB802_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 20HIS A 207TYR A 240TYR A 258PHE A 260 | NoneNone6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 1.20A | 2h21B-5kjmA:12.7 | 2h21B-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.55A | 2h21C-5kjmA:11.1 | 2h21C-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 20HIS A 207TYR A 240TYR A 258PHE A 260 | NoneNone6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 1.16A | 2h21C-5kjmA:11.1 | 2h21C-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 20LEU A 21TYR A 240TYR A 258PHE A 260 | NoneNone6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 1.45A | 2h21C-5kjmA:11.1 | 2h21C-5kjmA:23.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R3A_A_SAMA304_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.09A | 2r3aA-5kjmA:5.9 | 2r3aA-5kjmA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R3A_A_SAMA304_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | HIS A 207TYR A 240CYH A 262CYH A 264LEU A 254 | None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A)None | 1.29A | 2r3aA-5kjmA:5.9 | 2r3aA-5kjmA:19.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MEK_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18GLU A 135ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.59A | 3mekA-5kjmA:43.2 | 3mekA-5kjmA:32.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MEK_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 20ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.13A | 3mekA-5kjmA:43.2 | 3mekA-5kjmA:32.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OOI_A_SAMA237_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.44A | 3ooiA-5kjmA:6.0 | 3ooiA-5kjmA:21.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OPE_A_SAMA7_0 (PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 16ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.17A | 3opeA-5kjmA:6.4 | 3opeA-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OPE_A_SAMA7_0 (PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.58A | 3opeA-5kjmA:6.4 | 3opeA-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OPE_A_SAMA7_0 (PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.09A | 3opeA-5kjmA:6.4 | 3opeA-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q07_A_WPPA300_2 (BETA-LACTAMASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 4 / 5 | CYH A 209TYR A 258THR A 247THR A 238 | ZN A 505 (-2.4A)6TM A 502 ( 4.2A)NoneNone | 1.26A | 3q07A-5kjmA:undetectable | 3q07A-5kjmA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q07_B_WPPB400_2 (BETA-LACTAMASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 4 / 5 | CYH A 209TYR A 258THR A 247THR A 238 | ZN A 505 (-2.4A)6TM A 502 ( 4.2A)NoneNone | 1.25A | 3q07B-5kjmA:undetectable | 3q07B-5kjmA:20.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QWP_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 9 / 12 | GLY A 18GLU A 135CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.65A | 3qwpA-5kjmA:43.2 | 3qwpA-5kjmA:32.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QWP_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 20CYH A 181ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.4A)SAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.17A | 3qwpA-5kjmA:43.2 | 3qwpA-5kjmA:32.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QXY_A_SAMA6734_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.64A | 3qxyA-5kjmA:13.6 | 3qxyA-5kjmA:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QXY_B_SAMB6735_0 (N-LYSINEMETHYLTRANSFERASESETD6TRANSCRIPTION FACTORP65) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.53A | 3qxyB-5kjmA:12.83qxyQ-5kjmA:undetectable | 3qxyB-5kjmA:21.993qxyQ-5kjmA:4.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RC0_A_SAMA484_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.51A | 3rc0A-5kjmA:12.5 | 3rc0A-5kjmA:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RC0_B_SAMB480_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.62A | 3rc0B-5kjmA:13.7 | 3rc0B-5kjmA:21.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQ4_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | ASN A 206HIS A 207TYR A 240PHE A 260CYH A 262 | SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)SAM A 501 (-3.6A) ZN A 505 (-2.3A) | 0.98A | 3rq4A-5kjmA:8.0 | 3rq4A-5kjmA:19.22 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3S7B_A_SAMA1000_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 11 / 11 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.11A | 3s7bA-5kjmA:62.1 | 3s7bA-5kjmA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3S7F_A_SAMA1000_0 (N-LYSINEMETHYLTRANSFERASESMYD2P53 PEPTIDE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 11 / 12 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.26A | 3s7fA-5kjmA:61.93s7fI-5kjmA:undetectable | 3s7fA-5kjmA:100.003s7fI-5kjmA:5.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3S7J_A_SAMA1000_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 11 / 11 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.23A | 3s7jA-5kjmA:60.3 | 3s7jA-5kjmA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S8P_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | ASN A 206HIS A 207TYR A 240PHE A 260CYH A 262 | SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)SAM A 501 (-3.6A) ZN A 505 (-2.3A) | 1.01A | 3s8pA-5kjmA:7.0 | 3s8pA-5kjmA:19.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TG4_A_SAMA434_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 10 / 10 | LYS A 17ARG A 19HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.20A | 3tg4A-5kjmA:59.8 | 3tg4A-5kjmA:99.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAS_B_ADNB401_2 (PUTATIVE ADENOSINEKINASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 4 / 5 | ALA A 222MET A 205THR A 238PHE A 184 | NoneNoneNone6TM A 502 (-3.4A) | 1.29A | 3vasB-5kjmA:undetectable | 3vasB-5kjmA:22.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BUP_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | ASN A 206HIS A 207TYR A 240PHE A 260CYH A 262 | SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)SAM A 501 (-3.6A) ZN A 505 (-2.3A) | 1.04A | 4bupA-5kjmA:6.9 | 4bupA-5kjmA:19.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E47_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.36A | 4e47A-5kjmA:6.8 | 4e47A-5kjmA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E47_B_SAMB800_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.35A | 4e47B-5kjmA:5.8 | 4e47B-5kjmA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E47_C_SAMC800_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.35A | 4e47C-5kjmA:6.8 | 4e47C-5kjmA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJ8_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESETD8) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 10 | LYS A 17ARG A 19ASN A 206HIS A 207TYR A 240 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.78A | 4ij8A-5kjmA:7.34ij8B-5kjmA:7.4 | 4ij8A-5kjmA:17.254ij8B-5kjmA:17.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJ8_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESETD8) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 10 | LYS A 17LEU A 204ASN A 206HIS A 207TYR A 240 | NoneNoneSAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.95A | 4ij8A-5kjmA:7.34ij8B-5kjmA:7.4 | 4ij8A-5kjmA:17.254ij8B-5kjmA:17.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJ8_B_SAMB501_0 (N-LYSINEMETHYLTRANSFERASESETD8) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 9 | LYS A 17ARG A 19ASN A 206HIS A 207TYR A 240 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.82A | 4ij8A-5kjmA:7.34ij8B-5kjmA:7.6 | 4ij8A-5kjmA:17.254ij8B-5kjmA:17.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JDS_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.36A | 4jdsA-5kjmA:7.3 | 4jdsA-5kjmA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JDS_B_SAMB401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.37A | 4jdsB-5kjmA:6.9 | 4jdsB-5kjmA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JDS_C_SAMC401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.37A | 4jdsC-5kjmA:7.3 | 4jdsC-5kjmA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JLG_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.42A | 4jlgA-5kjmA:undetectable | 4jlgA-5kjmA:20.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4YND_A_SAMA505_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 10 / 10 | LYS A 17ARG A 19HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.26A | 4yndA-5kjmA:57.7 | 4yndA-5kjmA:99.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNM_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.00A | 4ynmA-5kjmA:6.5 | 4ynmA-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNM_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.46A | 4ynmB-5kjmA:6.7 | 4ynmB-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.03A | 4ynpA-5kjmA:6.5 | 4ynpA-5kjmA:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.17A | 4ynpA-5kjmA:6.5 | 4ynpA-5kjmA:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.37A | 4ynpA-5kjmA:6.5 | 4ynpA-5kjmA:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 10 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.36A | 4ynpB-5kjmA:6.7 | 4ynpB-5kjmA:20.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_A_SAMA3004_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.03A | 4ypaA-5kjmA:6.3 | 4ypaA-5kjmA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.93A | 4ypaB-5kjmA:6.5 | 4ypaB-5kjmA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_C_SAMC2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.01A | 4ypaC-5kjmA:6.4 | 4ypaC-5kjmA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_D_SAMD2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.95A | 4ypaD-5kjmA:6.4 | 4ypaD-5kjmA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.99A | 4ypeA-5kjmA:6.6 | 4ypeA-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPE_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 11 | LYS A 17GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.97A | 4ypeB-5kjmA:6.8 | 4ypeB-5kjmA:19.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPU_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.46A | 4ypuA-5kjmA:6.6 | 4ypuA-5kjmA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPU_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.16A | 4ypuA-5kjmA:6.6 | 4ypuA-5kjmA:20.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ARF_A_SAMA1002_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 12 / 12 | LYS A 17GLY A 18ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ALA A 203HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-4.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.50A | 5arfA-5kjmA:58.6 | 5arfA-5kjmA:98.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ARG_A_SAMA1434_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 10 / 11 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.60A | 5argA-5kjmA:58.8 | 5argA-5kjmA:98.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ARG_A_SAMA1434_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 10 / 11 | LYS A 17ARG A 19HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.44A | 5argA-5kjmA:58.8 | 5argA-5kjmA:98.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AYF_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 182ASN A 206HIS A 207TYR A 240 | SAM A 501 ( 4.1A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.35A | 5ayfA-5kjmA:6.6 | 5ayfA-5kjmA:19.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CCL_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 9 / 12 | GLY A 18GLU A 135CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.64A | 5cclA-5kjmA:42.8 | 5cclA-5kjmA:32.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CCL_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 20CYH A 181ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.4A)SAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.18A | 5cclA-5kjmA:42.8 | 5cclA-5kjmA:32.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CCM_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18GLU A 135ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.57A | 5ccmA-5kjmA:43.3 | 5ccmA-5kjmA:32.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CCM_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 20ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.16A | 5ccmA-5kjmA:43.3 | 5ccmA-5kjmA:32.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H4D_A_BBIA403_1 (NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-3,MITOCHONDRIAL) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 4 / 6 | PHE A 184PHE A 34GLU A 235VAL A 236 | 6TM A 502 (-3.4A)NoneNoneNone | 1.17A | 5h4dA-5kjmA:undetectable | 5h4dA-5kjmA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JHN_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.56A | 5jhnA-5kjmA:6.6 | 5jhnA-5kjmA:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JHN_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.57A | 5jhnB-5kjmA:6.1 | 5jhnB-5kjmA:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JIY_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.55A | 5jiyA-5kjmA:6.0 | 5jiyA-5kjmA:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JIY_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.58A | 5jiyB-5kjmA:6.0 | 5jiyB-5kjmA:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JJ0_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.61A | 5jj0B-5kjmA:6.0 | 5jj0B-5kjmA:18.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJK_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 11 / 11 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.11A | 5kjkA-5kjmA:62.2 | 5kjkA-5kjmA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJL_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 11 / 11 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.20A | 5kjlA-5kjmA:60.5 | 5kjlA-5kjmA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJM_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 11 / 11 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.00A | 5kjmA-5kjmA:64.1 | 5kjmA-5kjmA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJN_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 11 / 11 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.34A | 5kjnA-5kjmA:60.8 | 5kjnA-5kjmA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LSU_B_SAMB1304_1 (HISTONE-LYSINEN-METHYLTRANSFERASENSD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 3 / 3 | ASN A 206TYR A 240CYH A 262 | SAM A 501 (-3.2A)6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.19A | 5lsuB-5kjmA:6.1 | 5lsuB-5kjmA:18.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T0K_A_SAMA1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.51A | 5t0kA-5kjmA:6.1 | 5t0kA-5kjmA:18.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T0K_B_SAMB1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.50A | 5t0kB-5kjmA:4.8 | 5t0kB-5kjmA:18.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T0M_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.58A | 5t0mB-5kjmA:5.9 | 5t0mB-5kjmA:18.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_A_SAMA401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 9 | LYS A 17ARG A 19ASN A 206HIS A 207TYR A 240 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.79A | 5tegA-5kjmA:8.45tegD-5kjmA:undetectable | 5tegA-5kjmA:17.035tegD-5kjmA:5.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_A_SAMA401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 9 | LYS A 17LEU A 204ASN A 206HIS A 207TYR A 240 | NoneNoneSAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.98A | 5tegA-5kjmA:8.45tegD-5kjmA:undetectable | 5tegA-5kjmA:17.035tegD-5kjmA:5.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_B_SAMB401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 10 | LYS A 17GLY A 18ARG A 19ASN A 206HIS A 207TYR A 240 | NoneSAM A 501 ( 4.1A)SAM A 501 (-3.7A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.77A | 5tegB-5kjmA:8.65tegE-5kjmA:undetectable | 5tegB-5kjmA:17.035tegE-5kjmA:5.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_B_SAMB401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 10 | LYS A 17GLY A 18LEU A 204ASN A 206HIS A 207TYR A 240 | NoneSAM A 501 ( 4.1A)NoneSAM A 501 (-3.2A)None6TM A 502 ( 3.6A) | 0.90A | 5tegB-5kjmA:8.65tegE-5kjmA:undetectable | 5tegB-5kjmA:17.035tegE-5kjmA:5.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.45A | 5ttfA-5kjmA:5.9 | 5ttfA-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.40A | 5ttfB-5kjmA:6.0 | 5ttfB-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.39A | 5ttfC-5kjmA:6.0 | 5ttfC-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_D_SAMD1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.31A | 5ttfD-5kjmA:6.7 | 5ttfD-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTG_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.32A | 5ttgA-5kjmA:6.7 | 5ttgA-5kjmA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTG_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.32A | 5ttgB-5kjmA:6.7 | 5ttgB-5kjmA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUY_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.47A | 5tuyA-5kjmA:6.2 | 5tuyA-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUY_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.55A | 5tuyB-5kjmA:6.7 | 5tuyB-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUZ_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.31A | 5tuzA-5kjmA:6.8 | 5tuzA-5kjmA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUZ_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.33A | 5tuzB-5kjmA:6.6 | 5tuzB-5kjmA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UPD_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASENSD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.02A | 5updA-5kjmA:6.3 | 5updA-5kjmA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UPD_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASENSD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.54A | 5updA-5kjmA:6.3 | 5updA-5kjmA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V21_A_SAMA1804_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.47A | 5v21A-5kjmA:5.9 | 5v21A-5kjmA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V21_A_SAMA1804_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | HIS A 137HIS A 207TYR A 240CYH A 262LEU A 254 | SAM A 501 (-3.9A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A)None | 1.11A | 5v21A-5kjmA:5.9 | 5v21A-5kjmA:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V21_A_SAMA1804_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.05A | 5v21A-5kjmA:5.9 | 5v21A-5kjmA:21.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V37_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.46A | 5v37A-5kjmA:43.4 | 5v37A-5kjmA:32.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V37_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18GLU A 135CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 0.69A | 5v37A-5kjmA:43.4 | 5v37A-5kjmA:32.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V37_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 20CYH A 181ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.4A)SAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.22A | 5v37A-5kjmA:43.4 | 5v37A-5kjmA:32.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V3H_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 10 / 10 | LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240PHE A 260 | NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)SAM A 501 (-3.6A) | 0.35A | 5v3hA-5kjmA:53.6 | 5v3hA-5kjmA:99.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9I_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.43A | 5v9iA-5kjmA:5.9 | 5v9iA-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9I_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.41A | 5v9iB-5kjmA:6.0 | 5v9iB-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9I_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.33A | 5v9iC-5kjmA:6.0 | 5v9iC-5kjmA:18.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9J_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.32A | 5v9jA-5kjmA:6.7 | 5v9jA-5kjmA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9J_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.31A | 5v9jB-5kjmA:6.0 | 5v9jB-5kjmA:20.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSC_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.49A | 5vscA-5kjmA:5.3 | 5vscA-5kjmA:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSC_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.48A | 5vscB-5kjmA:5.9 | 5vscB-5kjmA:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSD_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.32A | 5vsdA-5kjmA:6.8 | 5vsdA-5kjmA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSD_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.34A | 5vsdB-5kjmA:6.7 | 5vsdB-5kjmA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSE_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.50A | 5vseA-5kjmA:6.1 | 5vseA-5kjmA:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSE_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.50A | 5vseB-5kjmA:5.9 | 5vseB-5kjmA:18.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSF_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.33A | 5vsfA-5kjmA:6.7 | 5vsfA-5kjmA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSF_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.34A | 5vsfB-5kjmA:6.8 | 5vsfB-5kjmA:20.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXD_A_SAMA501_0 (SMYD3METHYLTRANSFERASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.42A | 5xxdA-5kjmA:43.3 | 5xxdA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXD_A_SAMA501_0 (SMYD3METHYLTRANSFERASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18GLU A 135CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 0.66A | 5xxdA-5kjmA:43.3 | 5xxdA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXD_A_SAMA501_0 (SMYD3METHYLTRANSFERASE) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 20CYH A 181ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.4A)SAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.24A | 5xxdA-5kjmA:43.3 | 5xxdA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXG_A_SAMA502_0 (SMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 9 / 12 | GLY A 18GLU A 135CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.63A | 5xxgA-5kjmA:43.3 | 5xxgA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXG_A_SAMA502_0 (SMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 20CYH A 181ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.4A)SAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.22A | 5xxgA-5kjmA:43.3 | 5xxgA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXJ_A_SAMA505_0 (SMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.43A | 5xxjA-5kjmA:43.4 | 5xxjA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXJ_A_SAMA505_0 (SMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18GLU A 135CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 0.67A | 5xxjA-5kjmA:43.4 | 5xxjA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5XXJ_A_SAMA505_0 (SMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 20CYH A 181ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.4A)SAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.19A | 5xxjA-5kjmA:43.4 | 5xxjA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJO_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260 | SAM A 501 ( 4.1A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A) | 0.47A | 5yjoA-5kjmA:43.2 | 5yjoA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJO_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 8 / 12 | GLY A 18GLU A 135CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258 | SAM A 501 ( 4.1A)SAM A 501 (-3.3A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 0.70A | 5yjoA-5kjmA:43.2 | 5yjoA-5kjmA:33.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YJO_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 6 / 12 | GLY A 20CYH A 181ASN A 182HIS A 207TYR A 240TYR A 258 | NoneSAM A 501 ( 3.4A)SAM A 501 ( 3.8A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A) | 1.21A | 5yjoA-5kjmA:43.2 | 5yjoA-5kjmA:33.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5K_A_SAMA805_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH6) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.47A | 6a5kA-5kjmA:6.0 | 6a5kA-5kjmA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5M_A_SAMA805_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH6) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.40A | 6a5mA-5kjmA:5.6 | 6a5mA-5kjmA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5M_A_SAMA805_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH6) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | HIS A 207TYR A 240CYH A 262CYH A 264LEU A 254 | None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A)None | 1.21A | 6a5mA-5kjmA:5.6 | 6a5mA-5kjmA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 16ASN A 206HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.36A | 6agoA-5kjmA:6.3 | 6agoA-5kjmA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.11A | 6agoA-5kjmA:6.3 | 6agoA-5kjmA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.03A | 6agoA-5kjmA:6.3 | 6agoA-5kjmA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.29A | 6agoA-5kjmA:6.3 | 6agoA-5kjmA:20.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BP4_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFIC) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.42A | 6bp4A-5kjmA:5.6 | 6bp4A-5kjmA:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BP4_B_SAMB505_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFIC) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.04A | 6bp4B-5kjmA:5.6 | 6bp4B-5kjmA:19.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CEN_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASENSD3) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 11 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.56A | 6cenA-5kjmA:6.0 | 6cenA-5kjmA:19.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.00A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.46A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.18A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homosapiens) | 5 / 12 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.36A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 |